Clinical Trial: Narrow QRS Ischemic Patients Treated With Cardiac Resynchronization Therapy (NARROW CRT)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Narrow QRS Ischemic Patients Treated With Cardiac Resynchronization Therapy
Brief Summary: Current recommendations require a QRS duration of ≥120ms as a condition for prescribing cardiac resynchronization therapy (CRT). This study was designed to test the hypothesis that patients with heart failure of ischemic origin, current indications for defibrillator implantation and QRS <120ms may benefit from CRT in the presence of marked mechanical dyssynchrony.
Detailed Summary:
Sponsor: Ospedale Santa Maria di Loreto Mare
Current Primary Outcome: heart failure clinical composite score [ Time Frame: 12 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: time to the first heart failure hospitalization or death [ Time Frame: up to 30 months ]
Original Secondary Outcome: Same as current
Information By: Ospedale Santa Maria di Loreto Mare
Dates:
Date Received: April 11, 2012
Date Started: January 2008
Date Completion:
Last Updated: October 15, 2016
Last Verified: October 2016